Tricaprylin alone increases plasma ketone response more than coconut oil or other medium-chain triglycerides: An acute crossover study in healthy adults

Current Developments in Nutrition

Volumn 1, Issue 4, 2017, Pages

  Vandenberghe, Camille ^a,b   St Pierre, Valérie ^a,b   Pierotti, Tyler ^c   Fortier, Mélanie ^a   Castellano, Christian Alexandre ^a   Cunnane, Stephen C ^a,b  

^a Research Center on Aging   (Canada)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

^c BISHOP'S UNIVERSITY   (Canada)

Author keywords

Acetoacetate; Beta hydroxybutyrate; Coconut oil; Ketones; Medium chain triglycerides; Tricaprin; Tricaprylin

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETOACETIC ACID; COCONUT OIL; KETONE; MEDIUM CHAIN TRIACYLGLYCEROL; TRICAPRILIN;

ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; GLUCOSE TRANSPORT; HUMAN; HUMAN EXPERIMENT; KETOGENIC DIET; MALE; MILK; NORMAL HUMAN; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE;

EID: 85040952599     PISSN: None     EISSN: 24752991     Source Type: Journal    
DOI: 10.3945/cdn.116.000257     Document Type: Article

References (21)

1. Cahill GF. Fuel metabolism in starvation. Annu Rev Nutr 2006;26:1-22
2. Cunnane SC, Courchesne-Loyer A, St-Pierre V, Vandenberghe C, Pierotti T, Fortier M, Croteau E, Castellano CA. Can ketones compensate for deteriorating brain glucose uptake during aging? Implications for the risk and treatment of Alzheimer's disease. Ann N Y Acad Sci 2016;1367:12-20
3. Owen OE, Morgan AP, Kemp HG, Sullivan JM, Herrera MG, Cahill GF. Brain metabolism during fasting. J Clin Invest 1967;46:1589-95
4. Drenick EJ, Alvarez LC, Tamasi GC, Brickman AS. Resistance to symptomatic insulin reactions after fasting. J Clin Invest 1972;51:2757-62
5. Cross H, Ferrie C, Lascelles K, Livingston J, Mewasingh L. Old versus new antiepileptic drugs: the SANAD study. Lancet 2007;370:314; author reply: 315-6
6. Seaton TB, Welle SL, Warenko MK, Campbell RG. Thermic effect of medium-chain and long-chain triglycerides in man. Am J Clin Nutr 1986;44:630-4
7. Martens B, Pfeuffer M, Schrezenmeir J. Medium-chain triglycerides. Int Dairy J 2006;16:1374-82
8. Henderson ST. Ketone bodies as a therapeutic for Alzheimer's disease. Neurotherapeutics 2008;5:470-80
9. Courchesne-Loyer A, Fortier M, Tremblay-Mercier J, Chouinard-Watkins R, Roy M, Nugent S, Castellano CA, Cunnane SC. Stimulation of mild, sustained ketonemia by medium-chain triacylglycerols in healthy humans: estimated potential contribution to brain energy metabolism. Nutrition 2013;29:635-40
10. Schönfeld P, Wojtczak L. Short-and medium-chain fatty acids in energy metabolism: the cellular perspective. J Lipid Res 2016;57:943-54
11. Gagnon RC, Peterson JJ. Estimation of confidence intervals for area under the curve from destructively obtained pharmacokinetic data. J Pharmacokinet Biopharm 1998;26:87-102
12. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001;125: 279-84
13. Ikeda Y, Okamura-Ikeda K, Tanaka K. Purification and characterization of short-chain, medium-chain, and long-chain acyl-CoA dehydrogenases from rat liver mitochondria: isolation of the holoand apoenzymes and conversion of the apoenzyme to the holoenzyme. J Biol Chem 1985;260:1311-25
14. Thevenet J, De Marchi U, Domingo JS, Christinat N, Bultot L, Lefebvre G, Sakamoto K, Descombes P, Masoodi M, Wiederkehr A. Medium-chain fatty acids inhibit mitochondrial metabolism in astrocytes promoting astrocyte-neuron lactate and ketone body shuttle systems. FASEB J 2016;30:1913-26
15. McGarry JD, Foster DW. The regulation of ketogenesis from octanoic acid: the role of the tricarboxylic acid cycle and fatty acid synthesis. J Biol Chem 1971;246:1149-59
16. Rojas-Morales P, Tapia E, Pedraza-Chaverri J. b-Hydroxybutyrate: a signaling metabolite in starvation response? Cell Signal 2016;28:917-23
17. Cotter DG, Schugar RC, Crawford PA. Ketone body metabolism and cardiovascular disease. Am J Physiol Heart Circ Physiol 2013;304: H1060-76
18. Castellano CA, Nugent S, Paquet N, Tremblay S, Bocti C, Lacombe G, Imbeault H, Turcotte É, Fulop T, Cunnane SC. Lower brain 18Ffluorodeoxyglucose uptake but normal 11C-acetoacetate metabolism in mild Alzheimer's disease dementia. J Alzheimers Dis 2015;43:1343-53
19. Costantini LC, Barr LJ, Vogel JL, Henderson ST. Hypometabolism as a therapeutic target in Alzheimer's disease. BMC Neurosci 2008;9 (Suppl 2):S16
20. Nugent S, Tremblay S, Chen KW, Ayutyanont N, Roontiva A, Castellano CA, Fortier M, Roy M, Courchesne-Loyer A, Bocti C, et al. Brain glucose and acetoacetate metabolism: a comparison of young and older adults. Neurobiol Aging 2014;35:1386-95
21. VanItallie TB, Nufert TH. Ketones: metabolism's ugly duckling. Nutr Rev 2003;61:327-41